Literature DB >> 25779322

Determination of compound kill kinetics against Mycobacterium tuberculosis.

Julie Early1, Torey Alling.   

Abstract

In this chapter, we describe how to determine the kill kinetics and minimum bactericidal concentration (MBC) of a compound against Mycobacterium tuberculosis. Techniques are described for three conditions: actively growing aerobic bacteria, and non-replicating bacteria induced by nutrient starvation and/or low pH. Each technique involves determining the number of viable bacteria in the presence of several concentrations of compound over 3 weeks. Guidelines for how to interpret the results, to determine if growth-inhibitory compounds are bactericidal or bacteriostatic and also whether compounds exhibit time-dependent or concentration-dependent kill are provided.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25779322     DOI: 10.1007/978-1-4939-2450-9_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis.

Authors:  Joshua O Odingo; Julie V Early; Jake Smith; James Johnson; Mai A Bailey; Megan Files; Junitta Guzman; Juliane Ollinger; Aaron Korkegian; Anuradha Kumar; Yulia Ovechkina; Tanya Parish
Journal:  Drug Dev Res       Date:  2019-03-20       Impact factor: 4.360

2.  Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular Mycobacterium tuberculosis.

Authors:  Samuel Njikan; Sara Ahmed; Alyssa Manning; Divya Awasthi; Yulia Ovechkina; Sultan Chowdhury; Arielle Butts; Tanya Parish
Journal:  Microbiol Spectr       Date:  2022-05-25

3.  A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.

Authors:  Shilah A Bonnett; Devon Dennison; Megan Files; Anumita Bajpai; Tanya Parish
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

4.  A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.

Authors:  Julie V Early; Steven Mullen; Tanya Parish
Journal:  PLoS One       Date:  2019-10-07       Impact factor: 3.240

5.  InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.

Authors:  Lindsay Flint; Aaron Korkegian; Tanya Parish
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.